Spectrum Pharma to continue lymphoma drug study - BusinessWeek
Spectrum Pharma to continue lymphoma drug studyBusinessWeekSpectrum Pharmaceuticals Inc. said Monday it will continue studying a potential lymphoma treatment and expects to ask for Food and Drug Administration approval throughout the next two years. The Irvine, Calif., company made the decision to continue its ...Spectrum Gets Nod From DMC To Continue Belinostat Study In T-Cell lymphomaRTT NewsIndependent Data Monitoring Committee Recommends Continuation of Spectrum ...Business Wire (press release)all 27 news articles��
Blog Content
Post a Comment